Donati et al. (2016) discovered that the PNPLA3 variant rs2294918 (A>G), which encodes the PNPLA3 K434E substitution, reduces PNPLA3 expression and mitigates the impact of the I148M variant on susceptibility to hepatic steatosis and liver injury. Here, PNPLA3 is linked to fatty liver disease.